Beyond glycemic metrics: Real-world benefits of connected insulin pens in type 1 diabetes

This publication has 24 references indexed in Scilit:

• Impact of Continuous Glucose Monitoring and its Glucometrics in Clinical Practice in Spain and Future Perspectives: A Narrative Review
  Advances in Therapy, 2024
• Ultrarapid Insulin Use Can Reduce Postprandial Hyperglycemia and Late Hypoglycemia, Even in Delayed Insulin Injections: A Connected Insulin Cap-Based Real-World Study
  Diabetes Technology & Therapeutics, 2024
• Longitudinal Trends in Glycemic Outcomes and Technology Use for Over 48,000 People with Type 1 Diabetes (2016–2022) from the T1D Exchange Quality Improvement Collaborative
  Diabetes Technology & Therapeutics, 2023
• Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)
  Diabetes Therapy, 2023
• Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis
  Diabetologia, 2022
• Missed and Mistimed Insulin Doses in People with Diabetes: A Systematic Literature Review
  Diabetes Technology & Therapeutics, 2021
• Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the “Gordian Knot”?
  Diabetes & Metabolism, 2021
• Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen
  Diabetes Technology & Therapeutics, 2020
• Examining the Relationship Between Pre- and Postprandial Glucose Levels and Insulin Bolus Timing Using Bluetooth-Enabled Insulin Pen Cap Technology and Continuous Glucose Monitoring
  Diabetes Technology & Therapeutics, 2020
• Algorithmic Evaluation of Metabolic Control and Risk of Severe Hypoglycemia in Type 1 and Type 2 Diabetes Using Self-Monitoring Blood Glucose Data
  Diabetes Technology & Therapeutics, 2003